TITLE

Attention-deficit/hyperactivity disorder: The road traveled and the road ahead

AUTHOR(S)
Jun, Allison
PUB. DATE
November 2009
SOURCE
American Journal of Health-System Pharmacy;11/15/2009, Vol. 66 Issue 22, p2003
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The author reflects on attention-deficit/hyperactivity disorder (ADHD) and its treatment. She provides general information on the definition of ADHD with details on its symptoms. She discusses several treatments for ADHD, including lisdexamfetamine, amphetamine derivatives, and stimulant therapy. She also discusses the risk of addiction and abuse when drugs for the treatment of ADHD are administered to patients.
ACCESSION #
47608997

 

Related Articles

  • ADHD medication causes hallucinations.  // Foods Matter (UK);Mar2009, p15 

    The article focuses on a U.S. Food and Drug Administration report citing that at least 1% to 2% of children with attention deficit hyperactivity disorder (ADHD) who are taking stimulant medication experience hallucinations as published in the periodical "Pediatrics." It notes that hallucinations...

  • Melatonin effects on sleep disorders in children with attention deicit hyperactivity disorder. Bahremand, Zahra; Hashemian, Peyman; Moharreri, Fatemeh; Soltani, Ehsan // Reviews in Clinical Medicine;2014, Vol. 1 Issue 4, p233 

    Attention deficit hyperactivity disorder is one of the most common psychiatric disorders in childhood. Around 25-50% of these children suffered from some kind of sleep disorder especially with chronic form of insomnia. The physicians usually have a plan for improving hyperactivity and attention...

  • Does Early Exposure to Stimulants Lead to Substance Use Disorders Later on? Prousky, Jonathan E. // Ethical Human Psychology & Psychiatry;2015, Vol. 17 Issue 1, p22 

    Attention deficit/hyperactivity disorder (ADHD) denotes childhood problems of hyperactivity, inattention, and impulsivity, leading to impairments in daily functioning, scholastic performance, and relationships with peers. Although the rationale for stimulant medication is to reduce the morbidity...

  • dextroamphetamine.  // Davis's Drug Guide for Nurses, 10th edition;2007, p373 

    The article presents a nursing guide to dextroamphetamine, a central nervous stimulant and amphetamine used for the treatment of narcolepsy and adjunct management of attention-deficit hyperactivity disorder. Indications and contraindications are mentioned. Adverse reactions to the drug are...

  • Psychostimulant use for children with ADHD in Australia. Prosser, Brenton; Reid, Robert // Journal of Emotional & Behavioral Disorders;Summer99, Vol. 7 Issue 2, p110 

    Presents data from Australia on psychostimulant production and prescription rates for children with attention-deficit/hyperactivity disorder (ADHD). How use of medication for ADHD is increasing in Australia; Prescription usage for ADHD in the United States; Methods used in collecting data for...

  • PRESCRIPTION STIMULANTS.  // Scholastic Choices;Apr/May2011, Vol. 26 Issue 6, p16 

    The article offers information on prescription stimulants and discusses its role in treating attention deficit hyperactivity disorder (ADHD).

  • Hyperactivity: Symptoms vs. medication side effects.  // Child Health Alert;Jan1998, Vol. 16, p2 

    Focuses on medications for the treatment of attention deficit hyperactivity disorder (ADHD). Most effective drugs for hyperactivity; Drugs that causes fewer side effects; Most common side effects of the stimulants.

  • Side effects of medications in children with AFHD. Huffman, Grace Brooke // American Family Physician;2/1/1998, Vol. 57 Issue 3, p551 

    Focuses on the side effects of drugs used to treat children with attention-deficit hyperactivity disorder (ADHD) may have on them, with emphasis on a trial conducted in order to draw a comparison of the side effects of methylphenidate and dexamphetamine by D. Efron, et al and appeared in the...

  • Attention please.  // New Scientist;11/5/2011, Vol. 212 Issue 2837, p4 

    The article discusses results of research by William Cooper of Vanderbilt University in Nashville, Tennessee and colleagues investigating the cardiovascular side effects of drugs used to treat attention deficit hyperactivity disorder (ADHD).

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics